Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert M Miller, FRCS MBBS
OpsonaTherapeutics Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Linz, Austria
- Research Site
Brussels, Belgium
- Research Site
Ghent, Belgium
- Research Site
Leuven, Belgium
- Research Site
Liège, Belgium
- Research Site
Prague, Czechia
- Research Site
Bordeaux, France
- Research Site
Paris, France
- Research Site
Toulouse, France
- Research Site
Berlin, Germany
- Research Site
Berlin, Germany
- Research Site
Bochum, Germany
- Research Site
Bonn, Germany
- Research Site
Cologne, Germany
- Research Site
Erlangen, Germany
- Research Site
Heidelberg, Germany
- Research Site
Mannheim, Germany
- Research Site
Münster, Germany
- Research Site
Tübingen, Germany
- Research Site
Groningen, Netherlands
- Research Site
Leiden, Netherlands
- Research Site
Nijmegen, Netherlands
- Research Site
Rotterdam, Netherlands
- Research Site
Bydgoszcz, Poland
- Research Site
Lodz, Poland
- Research Site
Szczecin, Poland
- Research Site
Warsaw, Poland
- Research Site
Warsaw, Poland
- Research Site
Barcelona, Spain
- Research Site
Barcelona, Spain
- Research Site
Barcelona, Spain
- Research Site
Madrid, Spain
- Research Site
Santander, Spain
- Research Site
Zurich, Switzerland
- Research Site
London, United Kingdom
- Research Site
Newcastle upon Tyne, United Kingdom
- Research Site
Los Angeles, California, United States
- Research Site
Washington D.C., District of Columbia, United States
- Research Site
Tampa, Florida, United States
- Research Site
Chicago, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 30 Jun 2016
- Completion
- 30 Jun 2016
- Last update posted
- 16 Feb 2017
- Registered enrollment
- 252
- Registry id
- NCT01794663
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.